T cells from human allergen-induced late asthmatic responses express IL-12 receptor β2 subunit mRNA and respond to IL-12 in vitro

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2877-2885

  Varga, E M ^a   Wachholz, P ^a   Nouri Aria, K T ^a   Verhoef, A ^a   Corrigan, C J ^a   Till, S J ^a   Durham, S R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 5; MESSENGER RNA; MONOCLONAL ANTIBODY; RECEPTOR SUBTYPE; RECOMBINANT INTERLEUKIN 12;

ADULT; ALLERGY TEST; ARTICLE; ASTHMA; BRONCHUS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG LAVAGE; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

EID: 0034283675     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2877     Document Type: Article

References (50)

1. Human atopen-specific types 1 and 2 T helper cell clones
2. + T cells in primary culture: Relationship to expression of allergic disease
3. Allergen-stimulated interleukin-4 and interferon-γ production in primary culture: Responses of subjects with allergic rhinitis and normal controls
4. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-γ expression
5. Environmental antigen-induced IL-13 responses are elevated among subjects with allergic rhinitis, are independent of IL-4, and are inhibited by endogenous 1FN-γ synthesis
6. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
7. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
8. IL-13 expression at the sites of allergen challenge in patients with asthma
9. Recombinant human interleukin 5 is a selective activator of human eosinophil function
10. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity
11. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner
12. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
13. RANTES- and interleukin-8-induced responses in normal human eosinophils: Effects of priming with interleukin-5
14. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
15. The late, but not the early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration
16. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
17. + T lymphocytes
18. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones
19. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
20. Lack of IL-12 signaling in human allergen-specific Th2 cells
21. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells
22. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
23. Expression of Il-12 and Il-13 mrna in asthma and their modulation in response to steroid therapy
24. + cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy
25. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
26. Antibodies to the IL-12 receptor β2 chain mark human Th1 but not Th2 cells in vitro and in vivo
27. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics
28. Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge
29. Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: Identification of HLA-DR and -DQ restricted T cell epitopes
30. Human late asthmatic reactions
31. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function
32. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: Relation to asthma symptoms, lung function, and bronchial responsiveness
33. Extensive apoptosis of lung T-lymphocytes maintained in vitro
34. Functional analysis of human bronchial mucosal T cells extracted with interleukin-2
35. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects
36. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma
37. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression
38. Ectopic expression of the IL-12 receptor-β2 in developing and committed Th2 cells does not affect the production of IL-4 or induce the production of IFN-γ
39. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor β2 chain expression and signaling
40. + T cell lines in atopic asthmatics, and atopic and non-atopic controls
41. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics
42. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma
43. + lymphocytes by inhibiting IL-12 production
44. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
45. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses
46. Role of IFN-γ in the inhibition of the allergic airway inflammation caused by IL-12
47. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways
48. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice
49. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
50. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice